Tag: ALS medicine

FDA, Regulations

FDA approves new ALS medicine in precedent-setting decision

April 25, 2023

Via: Biopharma Dive

The Food and Drug Administration has conditionally approved a new ALS medicine in a decision likely to influence how other experimental treatments for the nerve-destroying disease are tested and reviewed. The medicine, known until now as tofersen, is only for […]